I Nkt Cell Therapy

Globe Newswire - Dec 18th, 2024
Score 7.8

MiNK Therapeutics to Present iNKT Cell Therapy in Gastric Cancer at ASCO GI Annual Meeting

Presentation will feature the ongoing Phase 2 study of agenT-797 in refractory gastric cancer Presentation will feature the ongoing Phase 2 study of agenT-797 in refractory gastric cancer

Previous Next

Showing 1 to 1 of 1 results